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Background: There is a need to reduce symptoms, exacerbations and improve quality of life for patients with
respiratory diseases. Across the world, increasing numbers of nurses are adopting the prescribing role and can
potentially enhance service provision. Evidence suggests improved quality of care and efficiencies occur when
nurses adopt the prescribing role. No evidence is available on the views of nurse prescribers who care for
respiratory patients. The aim was to explore how nurse prescribing is being used for patients with respiratory
conditions in different care settings across one strategic health authority, and whether this has benefited patients,
healthcare professionals and the National Health Service.
Methods: A qualitative study involving semi-structured interviews with a purposive sample of 40 nurses who
prescribed for respiratory patients across the six counties in the East of England Strategic Health Authority. Data
were collected in 2011 and subject to thematic analysis.
Results: Disease management, including treatment and prevention of exacerbations, emergency episodes and
minor illness, optimising and co-ordinating care were key aspects of care provided. Findings are reported under
three themes: access, adherence and risk management and impact on nurses. Prescribing enabled nurses overcome
existing problems in service provision to improve access, efficiency and patient convenience, reducing hospital
admissions and length of stay. It also enabled patient centered consultations, which encouraged self-management,
improved adherence, helped manage expectations, and reduced inappropriate service use. While participants
experienced increased job satisfaction, knowledge and confidence, concerns were raised about increased
responsibility, support, governance and future commissioning of services in line with planned major changes to
the National Health Service.
Conclusions: This study provides new knowledge about how nurse prescribers provide care to patients with
respiratory diseases. Despite a lack of consensus over the most effective model of respiratory care, prescribing was
reported to have improved and extended points of access to treatment, and supported management of complex
patients, particularly vulnerable groups. Given the high burden of chronic respiratory disease to patients and
families this has important implications that need to be considered by those responsible for commissioning
services in the United Kingdom and other countries.
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Chronic disease (CD), the main reason why people seek
healthcare in the developed world [1-3], encompasses a
set of progressive and long-term medical conditions in-
cluding respiratory diseases such as asthma and chronic
obstructive pulmonary disease (COPD) [2,4,5]. Around
300 million individuals are affected by asthma [6] and 10%
of adults aged over 40 years have COPD across the world
[7,8]. Asthma and COPD are both treatable conditions,
the aim of which, whatever the severity, is to minimize
and manage symptoms (GINA 2011, GOLD 2010). Des-
pite this, many patients experience high levels of symp-
toms, poor quality of life, and exacerbations that are a
common cause of emergency hospital admissions [9-11].
Each year in the United Kingdom (UK), £286 million is
spent on 110,000 admissions for COPD [10,12], and £61
million on 80,000 admissions for acute asthma attacks
[11]. In addition to hospital admissions, there are a number
of other significant direct costs (e.g. medication and on-
going management), and indirect costs (e.g. time lost from
work or school or premature death) associated with the
management of these diseases (GINA 2011, GOLD 2010).
Traditional healthcare systems, largely built around an
acute, episodic model of care, are ill-equipped to meet the
requirements of those with conditions such as asthma and
COPD [5,13,14]. Many countries are responding to the
global problem of changing demands on healthcare by
seeking to improve primary care services in order to re-
duce hospital admissions for people with long term condi-
tions (LTC) [13,15]. In order to meet this changing
requirement the contribution of non-medical health pro-
fessionals, particularly nurses, has increased in recent
years [15,16]. It is recognized that nurses have lead roles
to play in the delivery of services to patients with chronic
respiratory diseases (CRD) such as asthma and COPD
[17], and when nurses incorporate advanced roles in to
their practice quality of care, access to services, and pa-
tient satisfaction improve [18-20].
Multidisciplinary working, that integrates clinicians
from primary and acute care services, is considered im-
portant in ensuring the provision of a comprehensive re-
spiratory service [9,21]. However, there is a lack of
consensus in the evidence as to the best strategy for pro-
viding care [17,22,23]. A qualitative study in the UK,
found that planning of respiratory care services was in-
consistent, dependent upon local decision making by or-
ganisations, and focused on a small number of high risk
people with complex needs [9,22].
In the UK, the pyramid of care for LTCs has been used
to differentiate risk levels of patients so that patients at
high risk of hospital admission can be targeted for case
management [24]. This has coincided with the introduc-
tion of new roles, such as community matron (CM) and
case managers. Although these roles have a specific remitto reduce hospital admissions [25,26], evidence of success
is lacking [14,23,27]. At the same time, as part of policy to
improve access to healthcare there has been an evolution
of nurse-led immediate-access services (such as walk-in
centres (WIC), minor illness clinics and out-of hours ser-
vices (OOH)) [28]. Consequently, a broad range of nurses
in both primary and secondary care, including specialist
nurses, practice nurses and nurse practitioners, now
encounter patients with acute and on-going respiratory
conditions [21,22].
Expanding nurses’ roles to include prescribing, is a key
component of the UK governments’ National Health
Service (NHS) modernization agenda [29-32]. In con-
trast to other countries, e.g. the United States, Australia
and Canada, in the UK nurse prescribing is not re-
stricted to advanced nurse practitioners [33-35]. Evi-
dence suggests that the majority of the 26,000 Nurse
Independent Prescribers (NIP), who have virtually the
same prescribing rights as doctors [36], are based in pri-
mary care, with an increasing number taking on the role
in secondary care [37,38] (see below overview of non-
medical prescribing (NMP) in the UK).
An overview of non-medical prescribing in the UK
Non-medical Prescribing (NMP)
A generic term used to describe healthcare profes-
sionals e.g. nurses, pharmacists and allied health profes-
sionals (radiographers, podiatrists, and physiotherapists)
and optometrists who have the legal capacity to prescribe
medicines using independent or supplementary prescrib-
ing once they have undergone a formal programme of
preparation.
Nurse Independent Supplementary Prescribers: first
level registered nurses who complete an educational
programme (27 taught days and 12 days in practice) are
awarded dual qualification.
a) Nurse independent prescribing (NIP)
May assess, diagnose and prescribe independently any
licensed or unlicensed drug, except some controlled
drugs for treatment of addiction within area of
competence [29,31,39,40]
b) Nurse supplementary prescribing (NSP)
 Form of dependent prescribing. Initial diagnosis
made by doctors, clinical management plan (agreed
by Dr, patient and NSP) details medicines that can
be prescribed within area of competence [30,32]
Other healthcare professionals
 Pharmacists, Physiotherapists and Podiatrists, can
train as independent and supplementary prescribers
[30,32]
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(i.e. radiographers) able to train as supplementary
prescribers [30]
Findings from two recent UK surveys designed to ex-
plore the therapy areas in which nurses prescribe, indicate
that around 35% contribute to the care of patients with re-
spiratory conditions [38,41]. Additional evidence from the
United States suggests Advanced Nurse Practitioners
practicing in respiratory care frequently prescribe medi-
cines for the management of acute and chronic respiratory
conditions [42], however international evidence exploring
the prescribing practices of nurses who care for patients
with respiratory conditions is lacking [33,35].
Although not specific to patients with respiratory con-
ditions, research in other CD areas, such as diabetes,
suggests that a number of benefits arise when nurses
adopt the prescribing role. Patients report that they like
the continuity of care, comprehensive information and
holistic care that they receive [43,44], whereas nurses re-
port improved access to medicines and cost savings
achieved through improved efficiency [45,46]. A recent
audit of 2,500 episodes of prescribing across 15 NHS
trusts in the north west of England reported that nurse
prescribing (NP) averted substantial numbers of general
practice (GP) and consultant appointments, reduced epi-
sodes of unscheduled care, reduced length of hospital
stay, prevented readmissions and identified numerous
cases of inappropriate prescribing [47].
Although nurses in general are positive about the adop-
tion of the role as prescriber [37] there are on-going con-
cerns surrounding inconsistent levels of support and
governance structures [48,49]. Barriers to nurse prescribing
have been reported including restrictions of local arrange-
ments, such as inability to computer generate prescrip-
tions, and organisational and policy restrictions [38,49].
No evidence is currently available on the views of
nurses who care for respiratory patients on the adoption
of prescribing in their practice or service provision. This
is important given the number of patients with CRD
who experience high levels of symptoms, poor quality of
life, and exacerbations and the high number of nurses
working in a variety of roles who prescribe medicines in
this area of practice.
Aim
The aim of the study was to explore how nurse prescrib-
ing is used for patients with respiratory conditions in
different care settings across one strategic health author-
ity (SHA). The main objective was to explore if and how
local developments in nurse prescribing have benefited
patients, healthcare professionals and the NHS.
At the time of the study, the NHS in England was di-
vided in to 10 areas and managed by SHAs. Each SHAhad the responsibility to manage healthcare organisa-
tions (including primary care trusts, acute trusts, mental
health trusts and GPs) across a large geographical area.
Methods
Design and Setting
In this paper we report on a set of interview data that
formed the third and final stage of a study that explored
how non-medical prescribing (NMP) (see overview of
NMP in UK) is used across the East of England (EOE)
SHA. In stage 3, a qualitative approach, using semi-
structured telephone interviews, was used to explore the
views of nurses who cared for patients with respiratory
conditions. Findings from phase 1 of this study, NMP
leads views on their role and the implementation of NMP
from a multi-organisational perspective, and phase 2, a
survey of NMPs across the EOE SHA have previously
been reported [38,48].
Participants
Participants were purposively selected from 138 respon-
dents in the aforementioned questionnaire [38] who re-
ported that they prescribed for patients with respiratory
conditions, and indicated that they would be interested
in taking part in further research. An information sheet
and invitation email, with a reminder two weeks later,
was sent to all eligible participants (all nurses) who pro-
vided contact details. Those interested (32%) contacted
the researcher to arrange an interview. A total of 40 in-
terviews with nurse prescribers were conducted, four
additional interviews were planned but not undertaken
as staff were unavailable during dates arranged for inter-
views. Consent was obtained before each interview and
procedures to protect confidentiality i.e. removing iden-
tifiable information from the transcripts explained.
Data collection
Semi-structured telephone interviews were conducted and
audio recorded by two experienced qualitative researchers
(NC, KS). The interview schedule was informed by the lit-
erature [33,37,48] and findings from phase 2, a survey of
NMPs across the EOE SHA [38]. The interview schedule
covered background information about nurse prescribers’
role and practice setting, scope of practice, general views
and experience of prescribing for patients with respiratory
conditions, difficulties arising from prescribing, support
and supervision. Interviews, lasting 40-60 minutes, were
held at mutually convenient times. Data collection took
place from September to November 2011.
Data analysis and rigor
A thematic analysis, a recognised method used to iden-
tify, analyse and report themes and patterns within inter-
view data was conducted [50]. Atlas Ti, a qualitative data
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and identification of themes. This was followed by further
discussion and interpretation between two researchers
(NC & KS) to identify areas of data convergence and over-
all interpretation of the themes. Saturation of the data was
achieved. Once themes were developed the data was ana-
lysed by job title to identify any differences. Member valid-
ation occurred in that an overview of the findings was
emailed to all participants in March 2013, who agreed and
acknowledged a high level of relevance in the reported
findings.
Ethical consideration
Ethical approval for the study was provided by the Univer-
sity of Surrey. The study was deemed a service evaluation
by Cambridgeshire Research Ethics Committee.
Results
Demographic details
Participants (n = 40) were from all six counties in the
EOE, and worked across a wide range of practice settings
(i.e. GP, hospital in and out patients, community, WICs,
OOHs and the prison setting), with 75.5% (n = 31) based
in primary care, and 32.5% (n = 13) working as GP nurses
(see Table 1). There was considerable variation (range 4-
100%) in the amount of time participants spent with
respiratory patients. Respiratory nurse specialists had a
dedicated role whereas it constituted only a small part of
the role of others who worked in WICs and or provided
minor illness services in GP.
There was similar variation in the frequency of pre-
scribing (range 2 to 50 times per week), which, in line
with the number of presentations of upper respiratory
tract infections and chest infections, tended to rise in
the winter months. Ninety five per cent (n = 38) used
NIP to prescribe a range of medicines e.g. bronchodila-
tors, mucolytics and steroids, anti-puritics, analgesia,
and antibiotics, inhaler devices, and nebulisers: a few
participants were also involved in providing oxygen
therapy.
Participants described how managing CRD, including
the treatment and prevention of exacerbations, emer-
gency episodes of respiratory care (no previous diagnosis
of CRD), minor illness and optimising and co-ordinating
care were key aspects of care provided (see overview of
respiratory care provided by NMPs).
Respiratory care provided by non-medical prescribers
Type of care episode
 Treating exacerbations [previous diagnosis of CRD]
(n = 35)
 Preventing exacerbations of CRD (n = 34)
 Minor respiratory illness (n = 21) Routine monitoring (n = 17)
 Optimise care within specialist respiratory service
(n = 8)
 Unscheduled episodes of respiratory care
[no previous diagnosis of LTC] (n = 5)
 Co-ordinate care (n = 5)
Diagnosis & scope of practice
 Diagnose exacerbations of CRD (n = 33)
 Treat pre-diagnosed respiratory condition (n = 19)
 Initial diagnosis of respiratory condition (n = 12)
 Diagnose acute respiratory condition [no previous
diagnosis of CRD] (n = 8)
Patient management
 Advice re self-management and education (n = 37)
 Initiate respiratory medicines (n = 33)
 Repeat prescribing (n = 20)
 Prescribe for co-morbidities (n = 17)
 Make recommendation(via patient notes, telephone,
letter or email for medicine(s) to be prescribed)
(n = 14)
(CRD = chronic respiratory diseases i.e. asthma or
chronic obstructive pulmonary disease)Themes
Three themes 1) access, 2) adherence and risk manage-
ment and 3) impact on nurses, explore the challenges
faced, and impact when prescribing for patients with re-
spiratory conditions.
Quotations are used to illustrate themes. To protect
anonymity of participants, references to names or places
have been removed from these quotations. Names have
been replaced by an ‘x’ where appropriate. Job titles have
been abbreviated to NC = nurse consultant, CRNS =
community respiratory nurse specialist, RNS = respira-
tory nurse specialist, CM = community matron/case
manager, NPr = Nurse practitioner, ENP = emergency
nurse practitioner.
Access
By prescribing, participants reported that they were able
to improve access to medicines, convenience for patients
and enhance service efficiency. They were able to over-
come problems with existing services in relation to a)
frail and housebound patients, b) gaps in routine care,
and c) access to treatment in hospital. Rapid detection
and treatment of acute episodes or exacerbations of re-
spiratory conditions was a care priority for all partici-
pants and was one of the most significant areas to which
prescribing contributed (see above overview of respira-
tory care provided by NMPs).
Table 1 Participant Information
n = 40 n = number of participants % of total sample
Job Title
General practice based nurses (nurse practitioner, practice nurse, practice nurse lead) 13 32.5
Community matrons (Long term condition case manager) 7 17.5
Paediatric nurses (nurse specialist, nurse practitioner, community children’s nurse) 6 15.0
Secondary care nurses (emergency nurse practitioner, critical care outreach, nurse consultant) 4 10.0
Hospital or mixed base respiratory nurse specialists 4 10.0
Community based respiratory nurses (lead nurses, specialist nurse, nurse consultant) 3 7.5









Primary care trust (including community trust, community mental health & provider services) 16 40.0
General practice 12 30.0
Acute 9 22.5
Other: walk in centre, out of hours, social enterprise 3 7.5
Setting
Primary care: community, walk in centre, out of hours, prison 15 37.5
Primary care: general practice 12 30.0
Secondary care 9 22.5
Primary & secondary care 4 10.0
Age range
25-35 yrs 2 5.0
36-45 yrs 7 17.5
46-54 yrs 21 52.5
55-64 yrs 4 10.0
Years qualified as a prescriber
1-2 years 3 7.5
3-5 years 16 40.0
> 5 years 20 50.0
Use of prescribing qualification
Independent prescribing 37 92.5
Supplementary prescribing 1 2.5
Independent & supplementary prescribing 1 2.5
Not prescribing 1 2.5
Specialist respiratory training
Yes (diploma, degree and/or masters level module, study days, other accredited learning) 34 85.0
No 6 15.0
Time spent on respiratory patients
Range 4-100%, Mean = 51%, Mode = 100%
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Many patients had multiple co-morbidities with complex
health, particularly mental health, and social care needs.
For these reasons, home visits were predominantly used
by CMs and CRNS to provide care, alongside nurse-led
community clinics. Being able to prescribe in the com-
munity was reported to increase access to medicines,
sometimes by days. This was said to contribute to faster
recovery and reduction in hospital admissions.
“the biggest thing for patients is the delay in getting
prescriptions, especially when they’re acutely unwell.
People that are not prescribers have to come back at
the end of the day, write a letter on a computer, fax it
over to the GP, check that they’ve got that fax, the GP
needs to read and agree with it and then a
prescription gets generated. Sometimes it takes up to
2 days, whereas if I’ve gone to see them I can
prescribe it there and then.” [p30, NC]
In order to maximise efficiency, preventative prescrib-
ing was often used for patients at risk of developing
acute exacerbations. This meant that some participants
in GP and the community issued advanced prescriptions
for antibiotics and/or steroids which, in the event of an
infection, could be used under the advice of the nurse.
Importantly, the immediacy of access to treatment re-
duced anxiety and panic symptoms as patients were
more confident that treatment was in hand.
“They can get the drug when they want it. Thinking
of exacerbations, this time of year, the patient’s main
fear is that they can’t get a GP’s appointment quickly
enough when they’re feeling unwell. Even if the GP is
happy to issue antibiotics and steroids because you’re
a known COPD, it can sometimes take 24-48 hours
for that to be delivered to them, and then they’re
starting to get into ‘panic mode’ and their breathing
gets worse.” [p29, CRNS]
Gaining agreement to prescribe for patients attached
to different GPs, remote access to patient records, and
electronic prescribing facilities were key challenges
facing nurses who wished to prescribe for patients in
the community. While improvements were underway,
nurses who prescribed for patients in their home were
unable to electronically prescribe and few had access to
electronic patient records. Incomplete referral informa-
tion meant nurses had to take a more detailed history,
and or contact the GP, all of which was time consuming.
“What we get on the referral is what we know. I think
we’ve had three more practices now go on to the
same system we’re on and the GPs are finally cominground to understanding that sharing their notes is a
benefit to all of us. So it is improving. I’ve now got
two [GP practices] on my caseload where I can see
their notes as well.” [p28, NC]
Gaps in routine care
Poor attendance for routine care was reported to be com-
mon for patients with CRD. By prescribing, nurses extended
the settings in which patients could access a complete pack-
age of care and was fundamental to providing routine care
for those who would not normally access it.
“If they said that we could no longer prescribe, that
would have a huge impact, especially on our client
group. And I would question that people probably
wouldn’t use our services if that they knew that we
couldn’t prescribe.” [p19, NPr]
Prescribing also enabled adaptations to services. In
place of disease specific clinics, for example, some par-
ticipants offered a single ‘one-stop-shop’ review appoint-
ment for patients with multiple LTCs. NP was felt to
improve the overall experience as it reduced waiting
times and travel costs by eliminating the need for pa-
tients to return to the practice setting to collect a pre-
scription, or see a GP.
“I can do their prescription there and then, whereas
sometimes they’d have to come back for it. For the
younger people, who have taken time off work, they
don’t want to come back again, and sometimes they
get angry or frustrated if it puts them out, so yes, it’s
much, much better for them that it’s done there and
then.” [p20, children’s community nurse]
Within immediate access services (such as WIC, OOH,
prison and minor illness clinics in GP) NPs offered same-
day appointments and/or telephone advice. Here, having
an NP on the team, expanded the type of care provided
and enabled provision beyond historical ways of working
(e.g. patient group directives). Participants believed that
compared to doctors they were more accessible and
available for consultations. Patients were able to access
medication and commence treatment sooner, reducing
the likelihood of worsening symptoms and or complica-
tions related to the respiratory condition.
“We pick things up earlier because they feel that they
can come and see us sooner than they would
normally go to a doctor, because they don’t want to
bother a doctor. So I think us doing prescribing and
monitoring and treating chest conditions means that
patients present earlier, they get less complications.”
[p8, NPr]
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used immediate access services for repeat medicines that
should have been obtained through GP.
“My main dealings are treating people with acute
respiratory problems. Their medicines’ (ran) out, or
they’re becoming ill with complications. That’s mainly
an out of hours setting. It is a benefit for them to
walk in to the walk-in centre. At least they’re getting
care somewhere.” [p15, NPr]Access to treatment in hospital
Within hospital, the length of time between assessment
and treatment was traditionally dependent upon access
to a doctor. Through NP, patients attending hospital (as
inpatients, outpatients or Accident and Emergency
(A&E)) were said to receive treatment more rapidly. The
speed and efficiency of NP was said to improve recovery
and contribute to reducing hospital stay, the number of
GP consultations and visits to A&E.
“It’s had an enormous difference to patient care. So if
they come to clinic and they’re exacerbating, we’re
able to act upon it straight away. It actually stops
them needing an appointment with the GP to start
the medication. It has prevented hospital admissions,
repeat consultations with the GPs and patients
coming to A&E because of delays in treatment.”
[p31, RNS]
Again, as a result of wider policy changes such as the
European working time directive (i.e. legislative changes
in 2004 which restricted the work hours of junior doc-
tors in the National Health Service and other healthcare
systems throughout Europe), certain services, such as
overnight critical care outreach, had become reliant on
the presence of a NP.
“Junior doctor hours have been cut quite dramatically,
especially the hospital at night and so at, 3 o’clock in
the morning there’s just not the doctors around, we
are relied upon to see a lot of patients which normally
would be seen by the medical staff.”
[p6, critical care outreach]Adherence and risk management.
Adherence
A common problem noted by participants was that many
patients used their medicines incorrectly. Poor adherence
was thought to be caused by a lack of understanding,
unsuitable prescribing and/or a lack of a self-management
plan.“If a child has an asthma exacerbation……when they
come to us [hospital clinic], they sometimes don’t
have an asthma plan, and they don’t know that they
can multi-dose, they think that 2 puffs is the max-
imum, so that’s quite suspect because they could re-
duce the amount of admissions they have and their
anxiety if they knew how to give things properly.”
[p39, paediatric NPr]
Providing education about self-management of asthma
and COPD was a crucial part of the care provided by all
participants. Key aspects included education related to
general asthma management, ensuring patients had good
inhaler technique, checking medication regimens, check-
ing patient adherence to regimens, developing self-
management plans, and smoking cessation advice. Spe-
cialist respiratory nurses were also involved in optimising
treatment, particularly for complex patients with multiple
conditions. The application of specialist prescribing
knowledge was said to enhance these processes.
Managing co-morbidities
Co-morbidity was described as common in this group of
patients and prescribing was described as challenging as
it required knowledge and understanding of potential
drug interactions and contraindications across a range of
conditions.
“A lot of our patients now, they’re on several disease
registers so they’ve actually got lots of things to
manage and managing medicines and the interactions
and the patients in front of you is quite difficult, it’s
very complicated.” [p7, NPr]
Building the confidence and skills required to under-
take complex decisions required support. There was
concern over situations where such support was not
readily available, particularly where specialist advice may
be required.
“[The prescribing qualification] makes you wary,
especially when you’re giving an inhaled corticosteroid
or prednisolone to a diabetic and you get all the
contraindications and red alerts. To begin with, that
was really scary, but with having support of my
manager and everything on the risks and benefits, it’s
all about weighing up those things, but over time you
get better at doing it.” [p29, RNS]
Prescribing and the patient consultation
Across all settings, by enabling nurses to complete epi-
sodes of care and provide a more seamless service, pre-
scribing produced subtle changes in the nature and
content of the consultation. For example, patients received
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on how to use them, and were more likely to receive
the intended treatment. This was thought to improve
consistency and adherence.
“It’s much more personal, you can go more in-depth,
where before I could prescribe it was a case of, “Right,
OK, I think you’ve got a chest infection”, and then
they’d perhaps have another appointment to come
and see someone who could just double check and
then give them medication as well, I’m like a one stop
shop now.” [P8, NPr]
In addition, prescribing was felt to contribute to
more holistic and patient centred care, partly due to
NPs high level of knowledge and experience in this
area of practice. Nurses were able to work closely
with the patient to explain treatment and develop a
personalised plan of care. This in turn encouraged pa-
tients to become more actively involved in decisions
about the management of their treatment. These fac-
tors were said to be beneficial in preventing exacerba-
tions and also for providing routine monitoring of
patients with CRD.
“The consultations are patient-centred, hopefully, so
obviously you can meet with the patient and the
patient can tell you what their agenda is and obviously
you can have a list and then form a plan together.”
[p18, NPr]
Within the hospital setting, being able to complete the
episode of care was felt to offer a more consistent stand-
ard of care, particularly in areas such as A&E where doc-
tors regularly changed as part of a rotation.
“If you are a prescriber working alongside a doctor
who is a locum, you will be guiding them to best
local practice or best evidence-based practice, because
it’s your department that you work in. So I think that
patients are getting a more consistent standard of
care across the department, so less variability for
regular conditions that the department sees.”
[p3, ENP]
For those working in the community, seeing patients
in their home environment helped tailor advice and
treatment to the person. This was due to a number of
factors; patients were thought to be more honest and
talkative at home, meeting family members or carers
was valuable for sharing information, and the nurse
could observe aspects of lifestyle that patients did not
disclose, such as the presence of pets or stockpiling
medicines.“When you go through the medication with them and
they’ll go to a cupboard and it’s full, you can pick up
very quickly if people are stockpiling or not taking
things, but don’t want to admit it because they’re
worried the doctor’s going to be cross. I’m in a much
better position to stop things or go back to the patient
and explain why they should be taking it.” [p25, CM]
Managing emergency or preventative medicine
Despite the benefits of prescribing, the causes of poor
adherence were complex and not easy to resolve. Provid-
ing an accurate assessment of patients with CRD was
sometimes difficult to achieve where patients under-
reported the severity of their condition.
“I think there’s under-reporting of symptoms in some
respects and because with some respiratory conditions
they’re very variable it’s actually quite difficult to make
a full assessment at times.” [p11, clinical lead]
Use of emergency services for what was considered
routine care raised concerns about the potential misuse
of medicines, in particular, preventative prescribing of
steroids and antibiotics. Patients were said to overuse
these medicines, even when they did not have the symp-
toms of an infection, because they immediately reduced
unpleasant symptoms of breathlessness and wheezing.
“One thing that often goes hand in hand respiratory
disorders is an anxiety disorder. So what you find is you
have your steroids and your antibiotics in the cupboard
and you’ve got all these lovely instructions on when to
use them. If their anxiety kicks off, which then makes
them short of breath and feel very het-up, they will use,
as a crutch, steroids and antibiotics.” [p24, CM]
Education about long-term side effects did not always
prevent misuse. It was recognised that social isolation
and anxiety further complicated the situation and could
heighten symptoms. Calling patients for review rather
than simply issuing repeat prescriptions was one way of
managing this risk, although non-attendance was a
problem. Other precautions included undertaking risk
assessments, restricting the number of repeat prescrip-
tions or requiring permission from a doctor for pre-
ventative medicines.
“We risk-assess people that we’re going to leave medi-
cations with, especially steroids. I think we’ve had one
or two that have actually abused it because they feel
so good when they’re on it. They come off of it and
then… and that’s all about education, saying when you
come off of this you’ll actually go back to this level.”
[p29, CRNS]
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use of services. Nurse specialists would explain to patients
that they would only prescribe for respiratory conditions.
In comparison, community nurses would prescribe repeat
medicines for other conditions, such as diabetes. This was
noted as being potentially problematic because without
appropriate follow-up, there was the possibility of missing
underlying issues around adherence.
“I have to judge each visit as it goes by the amount of
stress I feel is going on in the home, but it is actually
counter-productive in the end because I can’t actually
monitor their level of usage. The reason they may
have run out may not be because they’re forgetful but
it might be because there’s poor compliance, or over-
use of medications.” [p21, CM]
Impact on Nurses
Job satisfaction, knowledge and confidence
Across all settings, the increased autonomy associated
with being able complete an episode of care through
prescribing gave participants more job satisfaction, sta-
tus, and respect from patients and other healthcare
colleagues.
“I think it’s been a marvelous thing really and it’s
been good, it’s good for my confidence, it’s given
me a lot to think about. It’s given me a new string
to a bow, it, keeps me interested.”
[p6, critical care outreach]
Prescribing was reported to increase knowledge and
confidence, maximise skills and enable participants to
take responsibility for decisions about patient manage-
ment. Nurses described how their learning accelerated
once they began to prescribe and took on the responsi-
bility of a more autonomous role.
“My knowledge is much better which means that I’m
much better at assessing patients. I’m much better at
giving advice to patients because I’ve got more
detailed knowledge about those drugs and how they
work and how they interact and it does allow for
opportunistic kind of advice for people who are
non-compliant in medication. It’s made me a much
better and more rounded nurse practitioner.”
[p3, ENP]
Prescribing was seen as essential to many roles, in-
cluding community matrons, case managers and respira-
tory nurse specialists:
“It makes a huge difference - there are some CMs and
case managers in our area that can’t prescribe andthey’re all desperate to get the qualification now
because once you start the job, you don’t realise what
an impact it has on your job until you’re doing it.”
[p24, CM]
Anxieties and concerns
With increased responsibility came increased anxiety re-
lated to the potential for making mistakes or being penal-
ized for prescribing decisions. Poor access to medical notes
was a concern (mainly in community and out-of-hours set-
tings). Developing competence to manage co-morbidities,
expand scope of practice and prescribe new medications
were challenging areas for some nurses. The extent to
which nurses took on new areas of practice varied and
depended on access to training, exposure to experience
and support. While anxiety was greatest during the initial
period after qualifying, confidence grew over time.
“I think the actual prescribing, you sort of grow into it
as you learn after the course. When I started, I
prescribed very, very few things, and hardly at all, and
over time I’ve gradually sort of grown in, into it as I’ve
learned more.” [p10, NPr]
Numerous concerns were raised about the future
commissioning, support and governance of NMP. A num-
ber of health trusts had recently undergone structural
reorganisation which had resulted in gaps in the provision
of support and leadership for NMP. Different attitudes of
new trust managers to, for example, accepting funding
from pharmaceutical companies for educational events,
had reduced provision of NMP support. In some cases,
trusts that previously supported an NMP lead, NMP
forum and educational updates had been assimilated into
a new trust that now provided only minimal support.
There were fears that within this climate of change,
where GPs and managers sought greater control over
stretched resources, roles were at stake and that the
value of NMP in contributing towards efficiency savings
may not be recognised. Concerns were also raised that
in the future, trusts and GPs would employ nurse pre-
scribers on lower grades with less experience, opt for
nurses to use patient group directions, and or restrict
what nurses can prescribe.
“I’m not sure my role will exist in the future. The GP
practice want their own case manager but paid at a
lower grade, someone who will prescribe, but only
want to pay a band six to, not a band seven, and there
are people with my prescribing skills at band five, so
they’ll definitely get someone. One of my colleagues
she’s actually limited in what she can prescribe
because they [as a GP] decide what they will and
won’t prescribe.” [p26, CM]
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This is the first study to explore prescribing by nurses
for patients with respiratory conditions.
Unlike areas such as diabetes, where nursing roles
have been explored in some detail [51,52], there is little
equivalent information in respiratory care against which
to compare those who prescribe [17,21]. The findings re-
veal that nurses across a wide spectrum of roles, titles,
and settings, prescribe for patients with respiratory con-
ditions. The variety of nursing roles in this SHA may re-
flect different patterns of local service provision for
respiratory diseases. Inconsistent strategic planning for
respiratory services was noted by Pinnock et al. (2009); a
situation that is not helped by the lack of consensus over
the most effective model for respiratory care [21,23].
Participants’ experience and contact with respiratory
patients varied, as did scope of practice and level of
decision-making. While the majority used prescribing
skills to manage exacerbations, provide education and
advice on self-management, there was considerable vari-
ation in the extent that individuals were involved in rou-
tine monitoring, the initial diagnosis of a respiratory
condition, initiating new medication, diagnosing and
treating minor illness and prescribing for co-morbidities.
Variations in the level of autonomy practiced by respira-
tory nurses in primary care have previously been re-
ported by Upton et al. [17]. Similarly, the extent that
nurse prescribers review patients independently of a
medical professional and are responsible for patient
management has been shown to vary [37,53]. While it is
evident that prescribing practice will be influenced by
service requirements, role variation, and skills mix
within teams, our results indicate that nurse prescribers
are increasingly working independently.
Despite variations in practice, the impact of prescribing
was reported as beneficial by participants in our study, to
the extent that the success of services had become
dependent upon nurses’ ability to prescribe. The findings
add to the body of evidence that NP is meeting its antici-
pated aim of improving access to medicines [29]. Across
all settings, participants reported improved access,
particularly amongst the more vulnerable. A key area to
benefit was the prevention and management of acute ex-
acerbations in high risk patients. This perhaps provides
some evidence that NP contributes to a reduction in hos-
pital admissions and length of stay, as shown in a recent
audit in the north west of England [47]. In contrast, the
findings of studies designed to explore nurse-led interven-
tions on hospital admission (such as case management),
have had mixed results [23]. Similarly, empirical work de-
signed to articulate the impact of the nurse prescribing
role on patient outcomes (such as a reduction in hospital
admissions) is also lacking; further evaluative research in
this area is therefore required.In addition to improving access to medicines, benefits
reported by participants in our study included more ap-
propriate advice and treatment, continuity of care, and im-
proved personalised care. These findings align with those
reported previously about nurse prescribing for other
LTCs [43,44]. Patients with LTCs are said to be more satis-
fied with, and value, nurses who can prescribe and practice
independently whilst maintaining a person-centred ap-
proach [19]. Our findings indicate that adoption of the
prescribing role by nurses improved the quality of medi-
cines advice and the promotion of self-management.
These benefits of NP are in-line with the aims of LTC
models which advocate personalised care planning [54].
There is evidence that patients with severe and complex
LTCs benefit less from educational self-management inter-
ventions [23]. Our findings suggest NP can help with the
management of patients with complex physical and social
problems. For example, nurses who visited patients in
their own home reported that they were able to make
more accurate holistic assessments based on a deeper
insight into personal or lifestyle factors, which in turn, im-
proved the effectiveness of prescribing decisions. In
addition, providing faster and more effective treatment
through prescribing was considered to impact on patients’
emotional health and reduced feelings of anxiety and
panic that can escalate respiratory conditions. This is im-
portant given that the high burden of CRD, in terms of
quality of life, to patients, families and carers [12].
Prescribing in community settings did, however,
present a set of challenges. It was evident from our find-
ings that nurses had to be successful at building good re-
lationships with GPs in order to gain agreement to
prescribe across different practices. Funding arrange-
ments and agreements were not always in place, creating
potential inequalities in service provision. Poor IT infra-
structures in community settings hampered access to pa-
tient records and electronic prescribing. These findings
support those reported by Lupari et al. [14] in a recent
review of the literature, that compared to other practice
settings, fewer governance systems and support for on-
going training and supervision are available for NPs in
community settings.
Shortfalls have previously been identified in the train-
ing of respiratory nurses in primary care: 20% of nurses
working in an advanced role (but not necessarily pre-
scribing) caring for patients with asthma, and 52% caring
for patients with COPD, were reported not to have ob-
tained accredited training [17]. Whilst the level of spe-
cialist training was high in our sample, there was a
general concern amongst participants about the level of
support available to prescribe new medicines and for pa-
tients with co-morbidities. Despite this, prescribing facil-
itated changes to the organisation of care for patients,
particularly those in GP, including the introduction of
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patients with multiple LTCs. Patients with multiple LTCs
are reported to dislike the disjointed care and less perso-
nalised consultation style they sometimes receive in dis-
ease specific clinics and would prefer to have all their
conditions considered in one appointment [19]. Managing
patients with complex conditions and co-morbidities re-
quires a high level of knowledge, decision-making and
autonomy that many NPs find challenging. In a survey by
Latter et al. [37], 58% of NIPs reported that they had
concerns about prescribing for patients who have co-
morbidities. This is an area that requires more attention
to ascertain how best to support NPs to develop complex
decision-making skills.
In line with Pinnock et al.’s [9] findings, there was some
indication of a need to improve routine care. Despite
the documented effectiveness and availability of self-
management plans, evidence suggests that they are not
routinely given out or used, and that non-use is strongly
associated with poor control [55]. Hamilton et al. [22]
argue that it important to provide a comprehensive service
across all areas of care rather than focus on the short-term
gains of reducing hospital admissions. They add that some
patients experience difficulty navigating the complex care
systems and wanted more flexibility over access [56]. In
our study, the points at which patients could access treat-
ment had been extended through nurses prescribing in
different settings. A perhaps unintended consequence of
this was that some patients wanted routine medication
prescribed in these new settings, such as walk-in-centres.
There is a risk that potential misuse of medication or mis-
understandings about medicines regimes may not be
picked up when patients access routine care outside of
GP. In addition there may be issues with lack of continuity
of care and lack of access to full medical history. The di-
lemma facing nurses in this situation is whether these
risks outweigh the benefits of providing immediate treat-
ment. We identified a number of strategies that nurses
used to assess and manage risk in these situations along-
side those related to prescribing of preventative treatment
for exacerbations. Our findings suggest that although GP
has historically been the preferred setting for provision of
routine care [21], a more flexible approach is required.
New technologies, such as telephone reviews, and use of
mobile technology as Worth et al. (2011) suggests offer in-
novative approaches to this aspect of care. For this to be
successfully achieved, fundamental changes to IT infra-
structure, access to medical records and local prescribing
arrangements would need to be addressed.
Limitations
As a qualitative study, we acknowledge that the findings
reflect the views of participants from one SHA who
volunteered to be interviewed. It should be consideredthat organisational arrangements for respiratory care
and nurse prescribing may vary across different geo-
graphical regions and as such may not represent the ex-
periences of NPs working in this practice area. There is,
however, no single model for respiratory care in the UK
or elsewhere. We are confident that the sample included
enough variation in participant roles and settings to pro-
vide a comprehensive picture of nurse prescribing in this
practice area. There are however, gaps in this picture
with respect to district nurses and health visitors, school
nurses and other non-medical prescribers such as phar-
macists, and physiotherapists who were not part of our
sample. In order that the views of patients with respira-
tory disease can be evaluated and understood further re-
search, using different methodologies, is required.
Conclusion
This study provides new knowledge about how nurse
prescribers provide care to patients with respiratory dis-
eases. Despite a lack of consensus over the most effective
model of respiratory care, prescribing was reported to
have improved and extended points of access to treat-
ment, and supported management of complex patients,
particularly vulnerable groups. Given the high burden of
chronic respiratory disease to patients and families this
has important implications that need to be considered
by those responsible for commissioning services in the
UK and other countries around the world.
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